Brief: Jade Biosciences Announces Proposed Underwritten Public Offering
03/06/2026 21:05
BRIEF-Jade Biosciences Announces Proposed Underwritten Public Offering June 3 (Reuters) - Jade Biosciences Inc JBIO.O:
JADE BIOSCIENCES ANNOUNCES PROPOSED UNDERWRITTEN PUBLIC OFFERING
JADE BIOSCIENCES - NET PROCEEDS TO FUND CLINICAL TRIALS, PRECLINICAL STUDIES, AND CORPORATE PURPOSES
Source text: ID:nGNXn7lr6
Further company coverage: JBIO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Jade Biosciences
See all newsBrief: Jade Biosciences Announces Preclinical Data Characterizing Jade301, A Potentially Best-In-Class, Half-Life-Extended Anti-Ifn-Β Monoclonal Antibody In Development For Dermatomyositis, At Eadv 2026
U.S. RESEARCH ROUNDUP-Cardinal Health, Lumentum Holdings, Public Storage
Jade Biosciences Inc reports results for the quarter ended June 30 - Earnings Summary
Jade Biosciences Q2 net loss widens as costs rise
Brief: Jade Biosciences, Inc Q2 Cash & Investments USD 461.2 Million